Pegylated liposomal doxorubicin and cyclophosphamide in early recurrent ovarian carcinoma: phase I dose-finding study.

about

Body surface area determined by whole-body CT scanning: need for new formulae?A new approach to integrate toxicity grade and repeated treatment cycles in the analysis and reporting of phase I dose-finding trials.

P2860

Q35753975-D40BB1AA-527C-4C57-9D49-3406BE2690F1 Q42697628-FD79152C-032F-4123-AD3B-718133E75197

P2860

Pegylated liposomal doxorubicin and cyclophosphamide in early recurrent ovarian carcinoma: phase I dose-finding study.

Item

http://www.wikidata.org/entity/Q44616736

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Pegylated liposomal doxorubici ...... a: phase I dose-finding study.

@en

Pegylated liposomal doxorubici ...... a: phase I dose-finding study.

@nl

type

Item

label

Pegylated liposomal doxorubici ...... a: phase I dose-finding study.

@en

Pegylated liposomal doxorubici ...... a: phase I dose-finding study.

@nl

prefLabel

Pegylated liposomal doxorubici ...... a: phase I dose-finding study.

@en

Pegylated liposomal doxorubici ...... a: phase I dose-finding study.

@nl

P1476

Pegylated liposomal doxorubici ...... a: phase I dose-finding study.

@en

P2093

Adélaïde Doussau

http://www.w3.org/2001/XMLSchema#string

Anne Floquet

http://www.w3.org/2001/XMLSchema#string

Jean-Philippe Dutin

http://www.w3.org/2001/XMLSchema#string

Laurent Cany

http://www.w3.org/2001/XMLSchema#string

Véronique Brouste

http://www.w3.org/2001/XMLSchema#string

P2860

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results.

Combination therapy with pegylated liposomal doxorubicin and carboplatin in gynecologic malignancies: a prospective phase II study of the Arbeitsgemeinschaft Gynäekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and Kommission Uterus (A

Intensified dose of cyclophosphamide with G-CSF support versus standard dose combined with platinum in first-line treatment of advanced ovarian cancer a randomised study from the GINECO group.

Efficacy of pegylated liposomal doxorubicin (PLD) plus carboplatin in ovarian cancer patients who recur within six to twelve months: a phase II study.

The role of pegylated liposomal doxorubicin in ovarian cancer: a meta-analysis of randomized clinical trials

Single agent carboplatin versus carboplatin plus pegylated liposomal doxorubicin in recurrent ovarian cancer: final survival results of a SWOG (S0200) phase 3 randomized trial.

Pegylated liposomal doxorubicin in the management of ovarian cancer

Trabectedin plus pegylated liposomal doxorubicin in relapsed ovarian cancer: outcomes in the partially platinum-sensitive (platinum-free interval 6-12 months) subpopulation of OVA-301 phase III randomized trial

Randomized trial of pegylated liposomal doxorubicin (PLD) plus carboplatin versus carboplatin in platinum-sensitive (PS) patients with recurrent epithelial ovarian or peritoneal carcinoma after failure of initial platinum-based chemotherapy (Southwe

P2888

s00280-013-2317-4

P304

61-68

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00280-013-2317-4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Simone Mathoulin-Pélissier

P577

2013-10-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24141374

http://www.w3.org/2001/XMLSchema#string

Pegylated liposomal doxorubicin and cyclophosphamide in early recurrent ovarian carcinoma: phase I dose-finding study.

about

P2860

P2860

Pegylated liposomal doxorubicin and cyclophosphamide in early recurrent ovarian carcinoma: phase I dose-finding study.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698